• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外生物素化可在一步操作中实现对高度纯化的活性乳糖通透酶的定量回收。

In vitro biotinylation provides quantitative recovery of highly purified active lactose permease in a single step.

作者信息

Pouny Y, Weitzman C, Kaback H R

机构信息

Howard Hughes Medical Institute, Department of Physiology, Molecular Biology Institute, University of California, Los Angeles 90095-1662, USA.

出版信息

Biochemistry. 1998 Nov 10;37(45):15713-9. doi: 10.1021/bi981519z.

DOI:10.1021/bi981519z
PMID:9843376
Abstract

Consler et al. [Consler, T. G., Persson, B. L., et al. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 6934-6938] described a one-step purification of lactose permease, a hydrophobic membrane transport protein, from Escherichia coli. Permease constructs containing a biotin acceptor domain are biotinylated in vivo, followed by solubilization and avidin affinity purification. Although a high degree of purity is obtained, only about 15-20% of the permease is recovered due to incomplete biotinylation. In this communication, a simple modification is described that allows quantitative recovery of highly purified permease. Membranes containing permease with the biotin acceptor domain from the Klebsiella pneumoniae oxaloacetate decarboxylase are extracted with 5 M urea or treated with dicyclohexylcarbodiimide to inactivate F1/Fo ATPase and biotinylated in vitro with biotin ligase, ATP and d-biotin. Subsequently, the membranes are harvested, washed to remove free biotin and solubilized with 2% n-dodecyl-beta-D-maltopyranoside. Biotinylated permease is then purified in one step by affinity chromatography on monomeric avidin-Sepharose. The purified material is homogeneous and exhibits full activity with respect to ligand binding and counterflow.

摘要

康斯勒等人[康斯勒,T.G.,佩尔松,B.L.等(1993年)《美国国家科学院院刊》90,6934 - 6938]描述了一种从大肠杆菌中一步纯化乳糖通透酶(一种疏水性膜转运蛋白)的方法。含有生物素受体结构域的通透酶构建体在体内进行生物素化,然后进行溶解和抗生物素蛋白亲和纯化。尽管获得了高度的纯度,但由于生物素化不完全,仅回收了约15 - 20%的通透酶。在本通讯中,描述了一种简单的改进方法,可实现高度纯化的通透酶的定量回收。用5 M尿素提取含有来自肺炎克雷伯菌草酰乙酸脱羧酶的带有生物素受体结构域的通透酶的膜,或用二环己基碳二亚胺处理以灭活F1/Fo ATP酶,并在体外使用生物素连接酶、ATP和d - 生物素进行生物素化。随后,收获膜,洗涤以去除游离生物素,并用2%的n - 十二烷基 - β - D - 麦芽糖苷溶解。然后通过在单体抗生物素蛋白 - 琼脂糖上进行亲和色谱一步纯化生物素化的通透酶。纯化后的物质是均一的,并且在配体结合和逆流方面表现出完全活性。

相似文献

1
In vitro biotinylation provides quantitative recovery of highly purified active lactose permease in a single step.体外生物素化可在一步操作中实现对高度纯化的活性乳糖通透酶的定量回收。
Biochemistry. 1998 Nov 10;37(45):15713-9. doi: 10.1021/bi981519z.
2
Purification and functional characterization of the C-terminal half of the lactose permease of Escherichia coli.大肠杆菌乳糖通透酶C末端一半的纯化及功能特性分析
Biochemistry. 1996 Apr 23;35(16):5213-9. doi: 10.1021/bi960064f.
3
Proximity between Glu126 and Arg144 in the lactose permease of Escherichia coli.大肠杆菌乳糖通透酶中谷氨酸126与精氨酸144之间的距离。
Biochemistry. 1999 Jun 8;38(23):7407-12. doi: 10.1021/bi9906524.
4
Probing the conformation of the lactose permease of Escherichia coli by in situ site-directed sulfhydryl modification.通过原位定点巯基修饰探究大肠杆菌乳糖通透酶的构象
Biochemistry. 1996 Apr 2;35(13):3950-6. doi: 10.1021/bi952601m.
5
Fluorescence of native single-Trp mutants in the lactose permease from Escherichia coli: structural properties and evidence for a substrate-induced conformational change.大肠杆菌乳糖通透酶中天然单色氨酸突变体的荧光:结构特性及底物诱导构象变化的证据
Protein Sci. 1995 Nov;4(11):2310-8. doi: 10.1002/pro.5560041108.
6
Fourier transform infrared analysis of purified lactose permease: a monodisperse lactose permease preparation is stably folded, alpha-helical, and highly accessible to deuterium exchange.纯化乳糖通透酶的傅里叶变换红外分析:一种单分散的乳糖通透酶制剂结构稳定,呈α螺旋状,且氘交换的可及性高。
Biochemistry. 1998 Nov 3;37(44):15363-75. doi: 10.1021/bi981142x.
7
Properties and purification of an active biotinylated lactose permease from Escherichia coli.来自大肠杆菌的活性生物素化乳糖通透酶的性质与纯化
Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):6934-8. doi: 10.1073/pnas.90.15.6934.
8
Ligand-induced movement of helix X in the lactose permease from Escherichia coli: a fluorescence quenching study.配体诱导的大肠杆菌乳糖通透酶中螺旋X的移动:一项荧光猝灭研究。
Biochemistry. 1997 Nov 18;36(46):14120-7. doi: 10.1021/bi9716433.
9
Characterization of Glu126 and Arg144, two residues that are indispensable for substrate binding in the lactose permease of Escherichia coli.对大肠杆菌乳糖通透酶中两个对于底物结合不可或缺的残基Glu126和Arg144的表征。
Biochemistry. 1999 Jan 12;38(2):813-9. doi: 10.1021/bi982200h.
10
A mutation in the lactose permease of Escherichia coli that decreases conformational flexibility and increases protein stability.大肠杆菌乳糖通透酶中的一种突变,该突变降低了构象灵活性并增加了蛋白质稳定性。
Biochemistry. 2003 Mar 18;42(10):3025-31. doi: 10.1021/bi027329c.

引用本文的文献

1
Biotin protein ligase as you like it: Either extraordinarily specific or promiscuous protein biotinylation.生物素蛋白连接酶:要么高度特异,要么滥竽充数的蛋白质生物素化。
Proteins. 2024 Apr;92(4):435-448. doi: 10.1002/prot.26642. Epub 2023 Nov 23.
2
Structure-guided design of an engineered streptavidin with reusability to purify streptavidin-binding peptide tagged proteins or biotinylated proteins.基于结构的工程化链霉亲和素设计,具有可重复使用性,可用于纯化带有链霉亲和素结合肽标签的蛋白质或生物素化蛋白质。
PLoS One. 2013 Jul 16;8(7):e69530. doi: 10.1371/journal.pone.0069530. Print 2013.
3
Site-directed alkylation of cysteine to test solvent accessibility of membrane proteins.
通过半胱氨酸的定点烷基化来测试膜蛋白的溶剂可及性。
Nat Protoc. 2007;2(8):2012-7. doi: 10.1038/nprot.2007.275.
4
Crystallization of a mammalian membrane protein overexpressed in Saccharomyces cerevisiae.在酿酒酵母中过表达的一种哺乳动物膜蛋白的结晶。
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11687-91. doi: 10.1073/pnas.0503986102. Epub 2005 Aug 8.
5
Purification of proteins using polyhistidine affinity tags.使用多组氨酸亲和标签纯化蛋白质。
Methods Enzymol. 2000;326:245-54. doi: 10.1016/s0076-6879(00)26058-8.
6
Membrane topology and insertion of membrane proteins: search for topogenic signals.膜蛋白的膜拓扑结构与插入:寻找拓扑信号
Microbiol Mol Biol Rev. 2000 Mar;64(1):13-33. doi: 10.1128/MMBR.64.1.13-33.2000.